SEC Form 4 · accession 0001646649-26-000033
Natera, Inc. · NTRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Sheena
Director · Other
Period of report
Sep 23, 2026
Accepted (ET)
Sep 25, 2026 · 9:35 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001604821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Sep 23, 2026 | S | 400 | $385.1025 | D | 17,632 | I | By Caraluna 1 Trust |
| Common StockF1,F4,F3 | Sep 23, 2026 | S | 2,175 | $386.7144 | D | 15,457 | I | By Caraluna 1 Trust |
| Common StockF1,F5,F3 | Sep 23, 2026 | S | 2,734 | $387.6545 | D | 12,723 | I | By Caraluna 1 Trust |
| Common StockF1,F6,F3 | Sep 23, 2026 | S | 1,293 | $388.7071 | D | 11,430 | I | By Caraluna 1 Trust |
| Common StockF1,F7,F3 | Sep 23, 2026 | S | 2,320 | $389.685 | D | 9,110 | I | By Caraluna 1 Trust |
| Common StockF1,F3 | Sep 23, 2026 | S | 110 | $390.42 | D | 9,000 | I | By Caraluna 1 Trust |
| Common StockF1,F8,F3 | Sep 23, 2026 | S | 390 | $385.2906 | D | 17,642 | I | By Caraluna 2 Trust |
| Common StockF1,F9,F3 | Sep 23, 2026 | S | 2,300 | $386.6396 | D | 15,342 | I | By Caraluna 2 Trust |
| Common StockF1,F10,F3 | Sep 23, 2026 | S | 2,846 | $387.7351 | D | 12,496 | I | By Caraluna 2 Trust |
| Common StockF1,F11,F3 | Sep 23, 2026 | S | 1,341 | $388.7637 | D | 11,155 | I | By Caraluna 2 Trust |
| Common StockF1,F12,F3 | Sep 23, 2026 | S | 1,935 | $389.7108 | D | 9,220 | I | By Caraluna 2 Trust |
| Common StockF1,F13,F3 | Sep 23, 2026 | S | 220 | $390.525 | D | 9,000 | I | By Caraluna 2 Trust |
| Common Stock | holding | — | — | — | 221,314 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
- F10The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $387.21 to $388.19 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F11The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $388.35 to $389.33 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F12The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $389.3650 to $390.2050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F13The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $390.42 to $390.63 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $385.0350 to $385.1900 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
- F4The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $386.1750 to $387.1700 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $387.21 to $388.12 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $388.3050 to $389.0400 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $389.3650 to $390.2850 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $385.0350 to $386.0150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F9The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $386.17 to $387.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.